San Antonio, TX, United States
San Antonio, TX, United States

Kinetic Concepts, Inc., is a global corporation that produces medical technology related to wounds and wound healing. KCI produced the first product developed specifically for negative pressure wound therapy. As of 2013 the company employs 5,000 people and markets its products in more than 25 countries. Its headquarters is in San Antonio, Texas. Wikipedia.


Time filter

Source Type

SAN ANTONIO--(BUSINESS WIRE)--Acelity, a global advanced wound care company, today announced that the PREVENA DUO™ Incision Management System is now available to physicians in the United States. The PREVENA DUO™ System is the first single use negative pressure wound therapy (NPWT) system designed specifically for the simultaneous management of two closed surgical incisions, configured to help reduce post-operative complications in bilateral procedures, such as vascular harvesting, breast reconstruction and orthopedic trauma surgeries. Acelity is the market leader in leveraging innovation to advance the art of healing. Acelity is applying that expertise to help clinicians better manage surgical incisions with the aim of reducing complications, expediting recovery and reducing unnecessary expense. In fact, more than 70 clinical publications supporting negative pressure incision management have been published. The effectiveness of the PREVENA™ Incision Management System or incisional V.A.C.® Therapy have established Acelity as the principal authority on the use of negative pressure for closed incisions. “ We are finding that surgeons around the world are adopting PREVENA™ Therapy as standard practice to provide care for their post-operative patients,” said Ron Silverman, M.D., Chief Medical Officer, Acelity. “ With the introduction of the PREVENA DUO™ Platform, Acelity is able to provide the same proven clinical benefits of negative pressure therapy that is specially configured for procedures where there are two closed incisions on the patient.” There are eight million people at risk for healthcare-associated infections (HAIs), and post-surgical complications can lead to significant costs. According to research published in The New England Journal of Medicine, surgical site infections (SSIs) are 21.8 percent of all HAIs, and these infections increase average length of hospital stay by an extra 9.58 days at an additional cost of $38,656.i “ SSIs encompass more than 20 percent of all HAIs and represent a significant burden both financially and psychologically for the patient, so there is a need to proactively address this issue,” said Allen Gabriel, MD of PeaceHealth Medical Group Plastic Surgery. “ With the PREVENA™ Incision Management System, surgeons can rely upon a significant body of clinical evidence demonstrating the system’s efficacy and coupled with its ease of use, ensures that we are doing all we can to help reduce this burden in an effort to improve outcomes for patients.” Clinical studies have demonstrated the efficacy of PREVENA™ Incision Management System in significantly reducing the incidence rate of infections. According to one study led by Tim Matatov, M.D., Louisiana State University Health Sciences Center, evaluating the PREVENA™ Incision Management System in reducing the risk of groin wound infection after vascular surgery, PREVENA™ Therapy was found to reduce the incidence of groin wound infection compared to traditional skin adhesive or absorbent dressings (6 percent incidence of infection with PREVENA™ Therapy compared to 30 percent with control group). As groin incisions are prone to complications and the incidence of groin SSIs after vascular surgery can be as high as 44 percent, prevention is a key component of improving patient care.ii The results also indicated significant cost savings with the PREVENA™ Incision Management System. In fact, the study authors concluded that the cost of the PREVENA™ System was quickly exceeded by the traditional dressings group due to long hospitalization required for two patients with Szilagyi Grade III infections ($25,740 vs. > $45,000 respectively).ii “ Until now, clinicians did not have the option to manage two incisions simultaneously with a single, disposable negative pressure source. The new PREVENA DUO™ Platform offers one efficient, easy-to-use method for providing therapy to these patients,” added Dr. Silverman. The PREVENA™ System, launched in 2010, is the first disposable Negative Pressure system designed specifically for the management of closed surgical incisions. The system covers and protects the incision from external contamination, while negative pressure removes fluid and infectious material from the surgical incision. Please refer to the Instructions for Use for the PREVENA™ Systems for a complete list of appropriate uses, warnings, and precautions. The PREVENA DUO™ Platform provides the power and clinical benefits of PREVENA™ Therapy and is available in unique configurations. Each configuration includes two easy to use PEEL & PLACE™ Dressings for management of linear incisions up to 20cm in length. The PREVENA DUO™ Platform is now available in the U.S. To learn more about the platform, visit prevena.com. Acelity L.P. Inc. and its subsidiaries are a global advanced wound care company that leverages the strengths of Kinetic Concepts, Inc. and Systagenix Wound Management, Limited. Available in more than 90 countries, the innovative and complementary ACELITY™ product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs nearly 5,000 people around the world. ii Matatov T, Reddy KN, Doucet LD, Zhao CX, Zhang WW. Experience with a new negative pressure incision management system in prevention of groin wound infection in vascular surgery patients. J Vasc Surg. 2013;57(3):791-5.


Global Negative Pressure Wound Therapy (NPWT) Market by Product Types, Growth Trends and Forecast to 2021, New Report by iHealthcareAnalyst, Inc. Negative Pressure Wound Therapy (NPWT) Market by Product Types (Conventional, Disposables, Canisters, Pumps, Dressing Kits, Single Use) and Forecast 2017-2021. Maryland Heights, MO, May 02, 2017 --( Browse Negative Pressure Wound Therapy (NPWT) Market by Product Types (Conventional, Disposables, Canisters, Pumps, Dressing Kits, Single Use) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/negative-pressure-wound-therapy-market/. The global negative pressure wound therapy market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global negative pressure wound therapy market segmentation is based on product types (conventional, disposables, canisters, pumps, dressing kits, single use). The global negative pressure wound therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global negative pressure wound therapy market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. Major players operating in the global negative pressure wound therapy market and included in this report are ArjoHuntleigh International AB, ConvaTec, Inc., Devon Medical, Inc., Genadyne Biotechnologies, Inc., Kinetic Concepts, Inc., Medela AG, Mölnlycke Health Care AB, Prospera Technologies LLC, Smith & Nephew PLC and Talley Group Limited. 1. Product Type 1.1. Conventional 1.1.1. Disposables 1.1.1.1. Canisters 1.1.1.2. Pumps 1.1.1.3. Dressing Kits 1.2. Single Use Negative Pressure Wound Therapy 2. Geography (Region, Country) 2.1. North America (U.S., Canada) 2.2. Latin America (Brazil, Mexico, Rest of LA) 2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 2.4. Asia Pacific (Japan, China, India, Rest of APAC) 2.5. Rest of the World 3. Company Profiles 3.1. ArjoHuntleigh International AB 3.2. ConvaTec, Inc. 3.3. Devon Medical, Inc. 3.4. Genadyne Biotechnologies, Inc. 3.5. Kinetic Concepts, Inc. 3.6. Medela AG 3.7. Molnlycke Health Care AB 3.8. Prospera Technologies LLC 3.9. Smith & Nephew plc 3.10. Talley Group Limited To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/negative-pressure-wound-therapy-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, May 02, 2017 --( PR.com )-- Negative-pressure wound therapy (NPWT) is a therapeutic technique using a vacuum dressing to promote healing in acute or chronic wounds and enhance healing of second and third degree burns. The therapy involves the controlled application of sub-atmospheric pressure to the local wound environment, using a sealed wound dressing connected to a vacuum pump. Negative pressure wound therapy is currently considered to be the most preferred choice of treatment by physicians as well as patients for such deep acute wounds and persistent chronic wounds. NPWT device uses an electrical suction pump to continuously or intermittently convey negative pressure through connecting tubes to specially designed wound dressings kits which includes resilient foam and gauze dressings and thereby promote faster wound healing. NPWT promotes wound healing by reducing edema, boosting granulation tissue and cell proliferation as well as by increasing blood circulation. NPWT systems can be used for treating surgical wounds, traumatic wounds, chronic wounds such as diabetic foot ulcers and venous stasis ulcers as well as pressure sores.Browse Negative Pressure Wound Therapy (NPWT) Market by Product Types (Conventional, Disposables, Canisters, Pumps, Dressing Kits, Single Use) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/negative-pressure-wound-therapy-market/.The global negative pressure wound therapy market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global negative pressure wound therapy market segmentation is based on product types (conventional, disposables, canisters, pumps, dressing kits, single use). The global negative pressure wound therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global negative pressure wound therapy market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.Major players operating in the global negative pressure wound therapy market and included in this report are ArjoHuntleigh International AB, ConvaTec, Inc., Devon Medical, Inc., Genadyne Biotechnologies, Inc., Kinetic Concepts, Inc., Medela AG, Mölnlycke Health Care AB, Prospera Technologies LLC, Smith & Nephew PLC and Talley Group Limited.1. Product Type1.1. Conventional1.1.1. Disposables1.1.1.1. Canisters1.1.1.2. Pumps1.1.1.3. Dressing Kits1.2. Single Use Negative Pressure Wound Therapy2. Geography (Region, Country)2.1. North America (U.S., Canada)2.2. Latin America (Brazil, Mexico, Rest of LA)2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)2.4. Asia Pacific (Japan, China, India, Rest of APAC)2.5. Rest of the World3. Company Profiles3.1. ArjoHuntleigh International AB3.2. ConvaTec, Inc.3.3. Devon Medical, Inc.3.4. Genadyne Biotechnologies, Inc.3.5. Kinetic Concepts, Inc.3.6. Medela AG3.7. Molnlycke Health Care AB3.8. Prospera Technologies LLC3.9. Smith & Nephew plc3.10. Talley Group LimitedTo request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/negative-pressure-wound-therapy-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill DriveMaryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com


News Article | May 5, 2017
Site: marketersmedia.com

— Market Research Future has a half cooked research report (HCRR) on global Tissue Engineering market which is expected to reach USD 12.6 billion from USD 5.2 billion from 2016 to 2022. Test the market data and market information presented in more than 50 market data tables and figures spread over 80 pages of the project report. Go through the in-depth table of content (TOC) & market synopsis on “Tissue Engineering Market Research Report- Global Forecast to 2022”. Market Highlights: It has been noted that global Tissue Engineering market is growing at rapid pace and is expected to grow tremendously at the CAGR of 22.2%. Globally there is huge demand for Tissue Engineering in various regions. Factors that influence the Tissue Engineering market are increasing technology advancement in healthcare which gives desired results, research area that aims at regenerative alternatives to harvested tissues for transplantation. Moreover increasing development in biological substitutes is influencing the global market for tissue engineering. Tissue engineering is a stimulating research area that aims at regenerative alternatives to collected tissues for transplantation. Biomaterials play a vital role as scaffolds to provide three-dimensional 3D templates and synthetic extracellular-matrix environments for tissue regeneration. It is often beneficial for the scaffolds to mimic certain advantageous characteristics of the natural extracellular matrix, or developmental or would healing programs. Some of the Major players of this market are those that holds the largest market share: • Sanofi (France) • BioMimetic Therapeutics (United States) • StemCellsInc (United States) • Zimmer Biomet (Indiana) • Medtronic (United States) • LifeCell Kinetic Concepts (United States) Other prominent vendors in the market are: • Cook Biotech (United States) • Arteriocyte (United States) • Acelity, Organogenesis (United States) • Athersys (United States) • RTI surgical (United States) • Integra LifeSciences (United States) • Advanced Cell Technology (United States) • CryoLife, (United States) Segmentation: Global Tissue Engineering market has been segmented on the basis of material which includes biomimetic materials synthesis, nano-fibrous materials, composite materials, nano-composite materials and others. Nano-fibrous materials has the largest market share in global Tissue Engineering by material and will be constant in future starting from 2016 lasting till 2022. The main reason for the growth of nano-fibrous material is many extracellular proteins have a fibrous structure with diameters on the nano-meter or sub-micrometer scales. Furthermore on the basis of end-user the market is segmented into Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Skin/Integumentary, Urology, Orthopedics, musculoskeletal and spine, Neurology and Cardiology & Vascular. Orthopedics contribute maximum to the growth of global Tissue Engineering by application due to increased incidence of sports-related injuries, musculoskeletal syndromes have become one of the major health concerns all around the globe. Moreover tissue engineering uses principles of engineering, biology, and chemistry, it provides a more operative approach to the treatment the musculoskeletal disorders than traditional methods. Brief TOC for Tissue Engineering Market: 1 Introduction 1.1 Definition 1.2 Scope of Study 1.3 Research Objective 1.4 Assumptions & Limitations 1.5 Market Structure 2 Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 3 Market Dynamics 3.1 Drivers 3.2 Restraints 3.3 Opportunities 3.4 Challenges 3.5 Macroeconomic Indicators 4 Market Factor Analysis 4.1 Porter’s five forces model 4.1.1 Bargaining Power of suppliers 4.1.2 Bargaining Power of Customer 4.1.3 Intensity of Competitor’s 4.1.4 Threat of New Entrants 5 Global Tissue Engineering Market, by Device material 5.1 Introduction 5.1.1 Biomimetic Materials Synthesis 5.1.2 Nano-Fibrous Materials 5.1.3 Composite Materials 5.1.4 Nano-Composite Materials Continue... Regional Analysis: Globally North America has the largest share in the tissue engineering market. North America holds about 47% market share for the global tissue engineering market. The share of this nation in this market is mainly due to increasing research and development in tissue engineering. Europe is the second-largest market for Tissue Engineering. Asia Pacific is expected to be fastest growing market for Tissue Engineering. Asia Pacific is expected to be the fastest growing market at a CAGR of 25.5% for the forecasted year from 2016 to 2022. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our cooked research report (CRR), half-cooked research reports (HCRR), raw research reports (3R), continuous-feed research (CFR) and market research & consulting services. MRFR team have prime objective to provide top quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end-users and market players for global, regional and country level market segments enables our clients to know more consequently do more, which help them in answering all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meeting with industry experts and does industrial visits for its research analyst members. For more information, please visit https://www.marketresearchfuture.com/


Regenerative Medicine Market is estimated at $20.07 billion in 2015 and is projected to reach $101.3 billion by 2022 growing at a CAGR of 26.0% from 2015 to 2022Pune , India - April 24, 2017 /MarketersMedia/ — Regenerative Medicine Industry Description According to Stratistics MRC, the Regenerative Medicine Market is estimated at $20.07 billion in 2015 and is projected to reach $101.3 billion by 2022 growing at a CAGR of 26.0% from 2015 to 2022. Growing research applications, growing demand in tissue engineering, biomaterials and stem cell therapy systems are some of the factors driving the market growth. However, high cost associated with biomaterials will be a major factor to restrict the market growth. The stem cells application and advancements in nanotechnology will further drive the market over the forecast period. Gene therapies segment is expected to be the fastest emerging technology due to tremendous potential of gene therapy in minimizing immune rejections, which commonly occur after transplantations. Asia-Pacific would be the fastest growing region for regenerative medicine market. Europe and North America together accounted for over 3/4th of the market revenue and anticipated to be most profitable regional market. Some of the key players in the market include Shire Pharmaceuticals, Advanced Cell Technology, Inc, Genzyme, Athersys, Inc., Kinetic Concepts, Inc., NuVasive Inc., Stem cells, Inc., Cytori Therapeutics, Inc., Cytomedix Inc., Mesoblast Ltd. , Zimmer Holdings, Inc., Orthofix, DePuy Synthes Inc., Cell Medica and CryoLife. Request for Sample Report @ https://www.wiseguyreports.com/sample-request/456590-regenerative-medicine-global-market-outlook-2015-2022 Technologies Covered: • Small Molecules and Biologics • Gene Therapy • Cell Therapy Applications Covered: • Dermatology • Cardiovascular Disorders • Central Nervous System (CNS) • Orthopedic • Dental • Other applications o Autoimmune Diseases o Muscle Regeneration o Ocular Diseases o Internal organ regeneration Leave a Query @ https://www.wiseguyreports.com/enquiry/456590-regenerative-medicine-global-market-outlook-2015-2022 Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=456590 Continued... Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) Contact Info:Name: NORAH TRENTEmail: sales@wiseguyreports.comOrganization: WISE GUY RESEARCH CONSULTANTS PVT LTDAddress: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028Phone: +91 841 198 5042Source URL: http://marketersmedia.com/regenerative-medicine-market-2017-global-share-trend-and-opportunities-forecast-to-2022/189453For more information, please visit https://www.wiseguyreports.com/sample-request/456590-regenerative-medicine-global-market-outlook-2015-2022Source: MarketersMediaRelease ID: 189453


News Article | March 2, 2017
Site: marketersmedia.com

— Market Research Future has a half cooked research report (HCRR) on global Tissue Engineering market which is expected to reach USD 12.6 billion from USD 5.2 billion from 2016 to 2022. Test the market data and market information presented in more than 50 market data tables and figures spread over 80 pages of the project report. Go through the in-depth table of content (TOC) & market synopsis on “Tissue Engineering Market Research Report- Global Forecast to 2022”. Market Highlights: It has been noted that global Tissue Engineering market is growing at rapid pace and is expected to grow tremendously at the CAGR of 22.2%. Globally there is huge demand for Tissue Engineering in various regions. Factors that influence the Tissue Engineering market are increasing technology advancement in healthcare which gives desired results, research area that aims at regenerative alternatives to harvested tissues for transplantation. Moreover increasing development in biological substitutes is influencing the global market for tissue engineering. Tissue engineering is a stimulating research area that aims at regenerative alternatives to collected tissues for transplantation. Biomaterials play a vital role as scaffolds to provide three-dimensional 3D templates and synthetic extracellular-matrix environments for tissue regeneration. It is often beneficial for the scaffolds to mimic certain advantageous characteristics of the natural extracellular matrix, or developmental or would healing programs. Some of the Major players of this market are those that holds the largest market share: • Sanofi (France) • BioMimetic Therapeutics (United States) • StemCellsInc (United States) • Zimmer Biomet (Indiana) • Medtronic (United States) • LifeCell Kinetic Concepts (United States) Other prominent vendors in the market are: • Cook Biotech (United States) • Arteriocyte (United States) • Acelity, Organogenesis (United States) • Athersys (United States) • RTI surgical (United States) • Integra LifeSciences (United States) • Advanced Cell Technology (United States) • CryoLife, (United States) Regional Analysis: Globally North America has the largest share in the tissue engineering market. North America holds about 47% market share for the global tissue engineering market. The share of this nation in this market is mainly due to increasing research and development in tissue engineering. Europe is the second-largest market for Tissue Engineering. Asia Pacific is expected to be fastest growing market for Tissue Engineering. Asia Pacific is expected to be the fastest growing market at a CAGR of 25.5% for the forecasted year from 2016 to 2022. Segmentation: Global Tissue Engineering market has been segmented on the basis of material which includes biomimetic materials synthesis, nano-fibrous materials, composite materials, nano-composite materials and others. Nano-fibrous materials has the largest market share in global Tissue Engineering by material and will be constant in future starting from 2016 lasting till 2022. The main reason for the growth of nano-fibrous material is many extracellular proteins have a fibrous structure with diameters on the nano-meter or sub-micrometer scales. Furthermore on the basis of end-user the market is segmented into Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Skin/Integumentary, Urology, Orthopedics, musculoskeletal and spine, Neurology and Cardiology & Vascular. Orthopedics contribute maximum to the growth of global Tissue Engineering by application due to increased incidence of sports-related injuries, musculoskeletal syndromes have become one of the major health concerns all around the globe. Moreover tissue engineering uses principles of engineering, biology, and chemistry, it provides a more operative approach to the treatment the musculoskeletal disorders than traditional methods. Brief TOC for Tissue Engineering Market: 1 Introduction 1.1 Definition 1.2 Scope of Study 1.3 Research Objective 1.4 Assumptions & Limitations 1.5 Market Structure 2 Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 3 Market Dynamics 3.1 Drivers 3.2 Restraints 3.3 Opportunities 3.4 Challenges 3.5 Macroeconomic Indicators 4 Market Factor Analysis 4.1 Porter’s five forces model 4.1.1 Bargaining Power of suppliers 4.1.2 Bargaining Power of Customer 4.1.3 Intensity of Competitor’s 4.1.4 Threat of New Entrants 5 Global Tissue Engineering Market, by Device material 5.1 Introduction 5.1.1 Biomimetic Materials Synthesis 5.1.2 Nano-Fibrous Materials 5.1.3 Composite Materials 5.1.4 Nano-Composite Materials Continue... About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our cooked research report (CRR), half-cooked research reports (HCRR), raw research reports (3R), continuous-feed research (CFR) and market research & consulting services. MRFR team have prime objective to provide top quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end-users and market players for global, regional and country level market segments enables our clients to know more consequently do more, which help them in answering all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meeting with industry experts and does industrial visits for its research analyst members. For more information, please visit https://www.marketresearchfuture.com/


News Article | December 7, 2016
Site: marketersmedia.com

According to Stratistics MRC, the Regenerative Medicine Market is estimated at $20.07 billion in 2015 and is projected to reach $101.3 billion by 2022 growing at a CAGR of 26.0% from 2015 to 2022. Growing research applications, growing demand in tissue engineering, biomaterials and stem cell therapy systems are some of the factors driving the market growth. However, high cost associated with biomaterials will be a major factor to restrict the market growth. The stem cells application and advancements in nanotechnology will further drive the market over the forecast period. Gene therapies segment is expected to be the fastest emerging technology due to tremendous potential of gene therapy in minimizing immune rejections, which commonly occur after transplantations. Asia-Pacific would be the fastest growing region for regenerative medicine market. Europe and North America together accounted for over 3/4th of the market revenue and anticipated to be most profitable regional market. Some of the key players in the market include Shire Pharmaceuticals, Advanced Cell Technology, Inc, Genzyme, Athersys, Inc., Kinetic Concepts, Inc., NuVasive Inc., Stem cells, Inc., Cytori Therapeutics, Inc., Cytomedix Inc., Mesoblast Ltd. , Zimmer Holdings, Inc., Orthofix, DePuy Synthes Inc., Cell Medica and CryoLife. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements For more information, please visit https://www.wiseguyreports.com/sample-request/456590-regenerative-medicine-global-market-outlook-2015-2022


Dublin, Dec. 23, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Advanced Wound Care and Closure Market Analysis & Trends - Product (Active Wound Care, Surgical Wound Care, Infection Management and Therapy Devices), Application (Chronic Wound Care and Acute Wound Care) - Forecast to 2025" report to their offering. Some of the prominent trends that the market is witnessing include increasing funding in wound care and development, rising geriatic population and impetus growth of disorders , increasing volume of surgeries across the globe, recent technological advancements in Advanced Wound Care and Closure, and growth opportunities/investment opportunities. Based on End-User the market is categorized into hospitals & specialty wound clinics, and home healthcare. Further is segmented into inpatient settings and long-term care facilities. Application segment is segregated into chronic wound care, acute wound care, and other applications. Chronic wound care is simultaneously sub-divided into arterial ulcers, diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other chronic wounds moreover; acute wound care is sub-divided into burns and surgical & traumatic wounds. Depending on products the market is categorized into active wound care, advanced wound dressings, surgical wound care, infection management, therapy devices, traditional/basic wound care, and other products. This industry report analyzes the global markets for Advanced Wound Care and Closure across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 4 Advanced Wound Care and Closure Market, By End-User 5 Advanced Wound Care and Closure Market, By Application 6 Advanced Wound Care and Closure Market, By Product 6.6 Traditional/Basic wound care 7 Advanced Wound Care and Closure Market, By Geography 8 Key Player Activities 9 Leading Companies - 3M Company - Acelity L.P. Inc. - Alliqua BioMedical, Inc. - BSN Medical GmbH - Baxter International Inc. - Coloplast A/S - Convatec Healthcare B S.À.R.L. - Covidien PLC (A Subsidiary of Medtronic Company) - Derma Sciences,Inc - Ethicon, Inc. - Holdings Corporation - Integra LifeSciences - Kinetic Concepts - Medtronic plc - Mölnlycke Health Care AB - Smith & Nephew PLC For more information about this report visit http://www.researchandmarkets.com/research/pjvn4j/advanced_wound


Patent
Kinetic Concepts | Date: 2010-07-14

A bariatric treatment system (100) providing a comprehensive array of therapeutic services for the morbidly obese patient (118) is disclosed. The treatment system (100) generally comprises a stable bed frame (101) upon which is mounted a low air loss therapeutic mattress system (104). Integrated hardware and software controls (170) provide such therapies such as pulsation, percussion, rotation, cardiac chair, and Trendelenburg. Means are disclosed whereby the bariatric patient (118) may safely and comfortably enter and exit the bed (100) with relative ease. The bed (100) is adaptable for transport within a hospital, including such features as a TRANSPORT MODE wherein its lateral axis is minimized and battery backup (178) is provided to maintain necessary therapies during patient transport. A plurality of control means are disclosed for simplification of caregiver workload and ease of patient utilization.


News Article | December 21, 2016
Site: www.businesswire.com

Até que a transação seja finalizada, a Acelity continuará a gerenciar os negócios da LifeCell, fornecendo disponibilidade total de produtos e suporte aos cirurgiões. A transação está sujeita à expiração ou término do período de espera previsto na lei de aperfeiçoamento antitruste Hart-Scott-Rodino de 1976 e ao cumprimento de outras condições habituais de fechamento. Na pendência de tais aprovações e do cumprimento de outras condições, a Acelity antecipa o fechamento da transação no primeiro semestre de 2017. A Acelity L.P. Inc. e suas subsidiárias são uma empresa global de tratamento avançado de lesões e medicina regenerativa, criada pela união dos pontos fortes de três empresas: Kinetic Concepts, Inc., LifeCell Corporation e Systagenix Wound Management, Limited. Disponível em mais de 80 países, o portfólio de produtos inovadores e complementares ACELITY™ agrega valor por meio de soluções que aceleram a cura e lideram o setor em qualidade, segurança e experiência do cliente. Sediada em San Antonio, Texas, a Acelity tem mais de 5.800 funcionários no mundo inteiro. O texto no idioma original deste anúncio é a versão oficial autorizada. As traduções são fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que é a única versão do texto que tem efeito legal.


Decubitus ulcers commonly occur on the elbows, back of the head, buttocks, heels, shoulders, hips, ankles, and back. Increasing incidences of decubitus ulcers and technological advancements in decubitus ulcer treatment products are some of the major factors driving the decubitus ulcer treatment market. Diagnosis of decubitus ulcer is based on clinical evaluation and nutritional assessment. Treatments for decubitus ulcer include pressure reduction, direct ulcer care, management of pain and control of infection, assessment of nutritional needs, and adjunctive therapy or surgery. Some of the required preventions include identification of high-risk patients, repositioning, conscientious skincare and hygiene, and avoidance of immobilization. On the basis of product, the decubitus ulcer treatment products market can be segmented into air fluidized beds, foam mattresses, alternative air pressure mattresses, low air loss beds, local area support products, and other full support products. Decubitus ulcer or pressure ulcer is an open wound on the skin. Decubitus ulcer occurs due to the breakdown of skin and underlying tissues through excessive pressure on an area of the skin. Some of the symptoms of decubitus ulcer are redness of the skin that worsens with time, and blisters on the area and then an open sore. Increasing incidences of decubitus ulcer, technological advancements, increasing aging population, government initiatives, and development of imagine technologies to enable early detection of ulcer are some of the major factors that are expected to drive the market for decubitus ulcer treatment products. In addition, growing incidences of chronic diseases and rise in awareness regarding the availability of decubitus ulcer treatment products are expected to drive the market for decubitus ulcer treatment products. However, high price of pressure ulcer relief products and economic downturn are some of the major factors restraining the growth of the global decubitus ulcer treatment products market. North America has the largest market for decubitus ulcer treatment products due to largest incidence of pressure ulcer, improved healthcare infrastructure, and technological advancements in this region. The North America decubitus ulcer treatment products market is followed by Europe. Asia is expected to witness high growth rate in the decubitus ulcer treatment products market in the next few years due to increasing demand for improved healthcare facilities, rise in awareness regarding pressure ulcer treatment products, improving healthcare infrastructure, and increasing patient population in the region. Growing population and economies in developing countries such as India and China are expected to drive the growth of the decubitus ulcer treatment products market in Asia. In addition, innovations along with technological advancements, growing awareness regarding decubitus ulcer treatment products, rise in incidences of chronic disorders, and introduction of cost-effective pressure ulcer treatment products are expected to create new opportunities for the global decubitus ulcer treatment products market. Increasing number of mergers and acquisitions, rising number of collaborations and partnerships, and product launches are some of the latest trends in the global decubitus ulcer treatment products market. Some of the major companies operating in the global decubitus ulcer treatment products market are Gaymar Industries, Inc., Invacare Corporation, Sunrise Medical, Inc., Graham-Field Health Products, Inc., and Hill-Rom Company, Inc. In addition, other companies operating in the global decubitus ulcer treatment products market include Spenco Medical, Corp., ROHO, Inc., James Consolidated, Inc., Kinetic Concepts, Inc., and Span-America Medical Systems, Inc.

Loading Kinetic Concepts collaborators
Loading Kinetic Concepts collaborators